• Building A Commons: How Bristol-Myers Squibb And BioTeam Used Gen3 To Build A New Data Paradigm

    Bio-IT World | Bristol-Myers Squibb wanted a fundamental change in how the big pharma approached data. They wanted a tool that ensured authentication and authorization, while empowering users to find well-characterized data they need, and a catalog all of the applications, tools, and analyses in use. With help from BioTeam, they found a solution in a custom Gen3 data commons.

    Jan 22, 2020

  • Franklin Award Opens Call For Nominations, Seeks Diversity

    Bio-IT World  The call for nominations is now open for the 2020 Benjamin Franklin Award, the award given annually recognizing open access in the life sciences. Nominations can be made by any member of Bioinformatics.org, a free membership organization. The organizers hope that more nominations will better reflect the diversity of the life sciences community.

    Jan 20, 2020

  • MGI Launches End-to-End Sequencing Platform With DNBSEQ-T7 Sequencer

    Bio-IT World | MGI, a subsidiary of BGI Group, has made a few announcements already this week: market clearance for its G and T Series sequencers in Asia Pacific countries and Europe, and an end-to-end genomics solution automating sample pre-processing through data analytics.

    Jan 15, 2020

  • The Healthcare Value Proposition For AWS’s New Data Exchange

    Bio-IT World | Amazon Web Services has launched AWS Data Exchange, a service that makes it easy for millions of AWS customers to securely find, subscribe to, and use third-party data in the cloud. ConvergeHEALTH by Deloitte is integrating tools to make the process particularly easy for healthcare data.

    Jan 15, 2020

  • Diagnostics Partnerships, New Sequencers, Technical Advances From Illumina

    Bio-IT World | Francis deSouza, CEO of Illumina, gave his report this morning at the annual JP Morgan Healthcare Conference. Just days after terminating the planned merger between Illumina and Pacific Biosciences, deSouza was positive about Illumina’s outlook for 2020, announcing agreements with Roche and Genomics England as well as new sequencers and technical advances. “I have never been more excited about the opportunity for Illumina as we enter 2020,” he said.

    Jan 13, 2020

  • Avoid These Eight Costly Biospecimen Procurement Mistakes

    Bio-IT World Contributed Commentary | Every day counts when it comes to saving lives and generating revenue, especially when you’re trying to bring a drug, treatment, or diagnostic tool to market. Unfortunately, these processes often take a lot longer and cost a lot more than initially expected.

    Jan 10, 2020

  • Top 10 Stories of 2019: National Genomic Data Initiatives, AI’s Impact in Drug Development, And More

    Bio-IT World | As we head into 2020, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.

    Jan 9, 2020

  • How To Improve Biopharmaceutical Research Data Utilization?

    Bio-IT World Contributed Commentary | Many enterprise network security people intuitively put everything behind a firewall—even though it has been well-established that firewalls are big hindrance to high-speed data flows. There are a few reasons of poor data mobility and thus low utilization.

    Jan 8, 2020

  • Follow the Money: New Life Sciences Investment Firm, Funding for Deep Genomics, Verantos, TwinStrand Biosciences, More

    Bio-IT World  Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies. Deep Genomics closes its series B round to fund its AI-powered drug discovery platform. Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology, and more.

    Jan 7, 2020

  • Heart-In-A-Jar Platform Humanizing Preclinical Research

    Bio-IT World | Stem cell biotech company Novoheart has been bioengineering miniature human hearts as a platform for drug discovery and development for several to pharmaceutical firms, notably for human conditions without a good animal model for preclinical testing. Novoheart’s thumb-sized human “heart-in-a-jar” models can both contract and eject blood-like fluid, making it possible to measure how well the heart is pumping.

    Jan 6, 2020

  • Keeping It Real: Challenges And Benefits Of Integrating AI And Machine Learning Into Pharma R&D

    Bio-IT World Contributed Commentary | Productivity in the pharmaceutical industry is rapidly declining. This crisis has created a need to re-think the way clinical trials are conceived, designed and conducted. As such, artificial intelligence is poised to transform the industry.

    Jan 3, 2020

  • Illumina, PacBio Terminate Merger Agreement

    Bio-IT World | Illumina and Pacific Biosciences of California today announced that they have mutually agreed to terminate their merger agreement. In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.

    Jan 2, 2020

  • 2020 Bio-IT Predictions: Digital Transformation Creates Opportunity and Obstacles

    Bio-IT World Contributed Commentary | They say change is good, but it’s best if you have the ability to adapt. That’s certainly the case in the IT space, where digital transformation continues to drive rapid advancement across virtually every industry, and certainly in the life sciences. Here are some predictions and potential challenges to consider heading into next year.

    Jan 2, 2020

  • Caris, GenScript, Fuzionaire, and More: News From December 2019

    Bio-IT World | December featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Caris, GenScript, Fuzionaire, and more.

    Dec 23, 2019

  • A Digital Transformation at the City of Hope

    Bio-IT World | City of Hope National Medical Center’s Chief Digital Officer discusses his role at City of Hope, the changing point-of-care landscape, and future digital transformations for the industry.

    Dec 19, 2019

  • A Regulatory View of Personalized Therapeutics

    Bio-IT World | The FDA’s Director of the Center for Biologics Evaluation and Research discusses the obstacles in developing gene therapies, emerging developments in the field, and the regulatory landscape surrounding personalized therapeutics.

    Dec 18, 2019

  • BioIVT Announces the Launch of its Next-generation Sequencing Service

    Bio-IT World News Brief | BioIVT today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities.

    Dec 16, 2019

  • Identifying Opportunities At The Interface Of Life Sciences And Tech

    Bio-IT World | Geraldine A. Van der Auwera calls herself a benevolent dictator. She boasts the pedigree of pre-doctoral and postdoctoral years in microbiology labs, and then a shift into computation. Now, as Director of Outreach and Communications, Data Sciences Platform, at the Broad Institute, she works with all camps—scientists, biomedical researchers, data scientists, technologists.

    Dec 16, 2019

  • An AI-Based Evolution of Clinical Communities

    Bio-IT World | AI can bring efficacious, precise, and effective diagnostics and therapeutics faster to the patient, and in the future, more efficient operations could save money, freeing up capital to invest in innovation.

    Dec 13, 2019

  • Has Validation In An Agile Software Development Environment Come Of Age?

    Bio-IT World Contributed Commentary | Today it is accepted that agile software development can work well within a formal project and most software vendors supplying the pharmaceutical industry have an agile aspect to their Software Development Life Cycle (SDLC).

    Dec 12, 2019